Full text is available at the source.
Abstract
Adults with type 2 diabetes have specific values and preferences regarding treatment options such as GLP-1 receptor agonists and SGLT-2 inhibitors.
- Values and preferences vary significantly among individuals when considering diabetes treatments.
- Perceived treatment burden plays a crucial role in the decision-making process for initiating new therapies.
- Patients may prioritize different aspects of medication based on personal experiences and health goals.
- Understanding these preferences could enhance shared decision-making between patients and healthcare providers.
Simplified